As of 2024-09-19, the Relative Valuation of Accelerate Diagnostics Inc (AXDX) is (58.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.47 USD, the upside of Accelerate Diagnostics Inc based on Relative Valuation is -4080.1%.
The range of the Relative Valuation is (61.37) - (54.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 38.3x - 44.5x | 41.4x |
| Forward P/E multiples | 30.6x - 33.8x | 31.6x |
| Fair Price | (61.37) - (54.11) | (58.51) |
| Upside | -4275.0% - -3780.7% | -4080.1% |
| Date | P/E |
| 2024-09-18 | -0.92 |
| 2024-09-17 | -0.92 |
| 2024-09-16 | -0.95 |
| 2024-09-13 | -0.95 |
| 2024-09-12 | -0.94 |
| 2024-09-11 | -1.01 |
| 2024-09-10 | -1.00 |
| 2024-09-09 | -0.99 |
| 2024-09-06 | -1.08 |
| 2024-09-05 | -1.06 |
| 2024-09-04 | -1.16 |
| 2024-09-03 | -1.23 |
| 2024-08-30 | -1.25 |
| 2024-08-29 | -1.19 |
| 2024-08-28 | -1.18 |
| 2024-08-27 | -1.19 |
| 2024-08-26 | -1.14 |
| 2024-08-23 | -1.11 |
| 2024-08-22 | -1.07 |
| 2024-08-21 | -1.05 |
| 2024-08-20 | -1.05 |
| 2024-08-19 | -1.14 |
| 2024-08-16 | -1.12 |
| 2024-08-15 | -1.04 |
| 2024-08-14 | -1.07 |
| 2024-08-13 | -1.12 |
| 2024-08-12 | -1.06 |
| 2024-08-09 | -0.91 |
| 2024-08-08 | -0.89 |
| 2024-08-07 | -0.84 |
| 2024-08-06 | -0.79 |
| 2024-08-05 | -0.72 |
| 2024-08-02 | -0.80 |
| 2024-08-01 | -0.83 |
| 2024-07-31 | -0.84 |
| 2024-07-30 | -0.80 |
| 2024-07-29 | -0.80 |
| 2024-07-26 | -0.81 |
| 2024-07-25 | -0.77 |
| 2024-07-24 | -0.78 |
| 2024-07-23 | -0.81 |
| 2024-07-22 | -0.72 |
| 2024-07-19 | -0.70 |
| 2024-07-18 | -0.71 |
| 2024-07-17 | -0.72 |
| 2024-07-16 | -0.71 |
| 2024-07-15 | -0.72 |
| 2024-07-12 | -0.72 |
| 2024-07-11 | -0.70 |
| 2024-07-10 | -0.71 |